BioSpace News Archive

Deals

Hill-Rom Announces Divestiture Of Third-Party Rental Business

Divestiture of non-core business enables greater focus on higher growth opportunities.

March 12, 2018
·
2 min read
Drug Development

Enrollment Completed in Phase 3 Registration Trial for Non-Muscle Invasive Bladder Cancer

Eleven Biotherapeutics’ VISTA Trial of Vicinium™ in NMIBC on-track for topline three-month data in mid-2018.

March 12, 2018
·
7 min read
Business

Jason Menzo Joins Foundation Fighting Blindness as Chief Operating Officer

Notable industry executive brings more than 15 years of ophthalmic experience and award winning achievement to FFB’s mission.

March 12, 2018
·
3 min read
Business

First Registered Dietitian in United States Certified in Wound Care by National Alliance of Wound Care and Ostomy®

The certified Registered Dietitian (RD)/Registered Dietitian Nutritionist (RDN) is a key member on the multi-disciplinary wound care team who understands both the underlying causes of wounds and how to support the patient with proper nutritional plans based on their needs.

March 12, 2018
·
2 min read
Biotech Bay

ITUS will Present Data at the American Association of Cancer Research (AACR) Annual Meeting

Data from its ongoing study utilizing Cchek™, ITUS’s artificial intelligence (AI) driven early cancer detection technology.

March 12, 2018
·
4 min read
Smartphone-based Retinal Imaging Together With Artificial Intelligence Powers Automated, Sensitive and Early Detection of Retinopathy

90% of the vision loss due to DR is preventable by early detection and timely treatment.

March 12, 2018
·
2 min read
Business

Sectra’s Nine-month Interim Report 2017/2018: Sectra Tops Customer Satisfaction for Fifth Consecutive Year

Sectra reported increased order bookings and net sales compared with the year-earlier period.

March 12, 2018
·
3 min read
Business

Chi-Med Reports Final Results for the Year Ended December 31, 2017 and Updates Shareholders on Key Clinical Programs

Chi-Med Reports Final Results for the Year Ended December 31, 2017 and Updates Shareholders on Key Clinical Programs

March 12, 2018
·
26 min read
Drug Development

NGM Bio Announces Publication In The Lancet Of Phase 2 Study Of NGM282 In NASH Patients And Upcoming Presentations Of NGM282 NASH Histology Data And NGM282 PSC Data At The International Liver Congress 2018

Statistically significant and clinically meaningful improvements observed in MRI measures of liver fat and serum biomarkers of liver function, lipid metabolism and fibrosis

March 12, 2018
·
5 min read
Business

ALASTIN Skincare, Inc. Announces Appointment of Ann Rhoads and Elisabeth Sandoval to Company’s Board of Directors

Alastin Skincare, Inc. is a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products with proprietary TriHex Technology® that enhance, protect, and maintain healthy skin for a lifetime

March 12, 2018
·
2 min read